A detailed history of Rothschild Investment LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Rothschild Investment LLC holds 1,105 shares of EXAS stock, worth $58,465. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,105
Previous 1,100 0.45%
Holding current value
$58,465
Previous $46.5 Million 61.96%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$42.43 - $70.83 $212 - $354
5 Added 0.45%
1,105 $75.3 Million
Q2 2024

Jul 30, 2024

BUY
$41.33 - $74.26 $45,463 - $81,686
1,100 New
1,100 $46.5 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.36B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.